World Leaders in Immune System Monitoring with Novel Molecular Biomarkers
Immunexpress technology is designed to diagnose and monitor immune system health and wellness using novel host response biomarkers.
Immunexpress is a molecular diagnostics company developing accurate clinical assays for the personalized management of immune disorders with a current focus on:
- • Early detection and personalized management of sepsis patients
- • Early identification of sepsis in patients at risk
Immunexpress technology is based on proprietary immune system blood biomarkers for adaptation to new and existing clinical diagnostic platforms (multiplex qRT-PCR and proteomic).
Immunexpress’s vision is to deliver its multiplex molecular assays on point-of-care (POC) platforms for rapid turnaround, improved patient outcomes, reduced healthcare costs, and more effective targeted therapies.
